Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
193,539,047
-
Number of holders
-
510
-
Total 13F shares, excl. options
-
176,035,547
-
Shares change
-
-1,709,705
-
Total reported value, excl. options
-
$14,685,174,801
-
Value change
-
-$129,382,414
-
Put/Call ratio
-
161%
-
Number of buys
-
224
-
Number of sells
-
222
-
Price
-
$83.44
Institutional Holders of BIOMARIN PHARMACEUTICAL INC - Common Stock, par value $0.001 per share (BMRN) as of Q2 2021
As of 30 Jun 2021 BIOMARIN PHARMACEUTICAL INC - Common Stock, par value $0.001 per share (BMRN) had 628 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 176,035,547 shares of stock of the company.
Largest 10 holders included Capital Research Global Investors, PRIMECAP MANAGEMENT CO/CA/, VANGUARD GROUP INC, Dodge & Cox, BlackRock Inc., BAKER BROS. ADVISORS LP, AMERIPRISE FINANCIAL INC, Clearbridge Investments, LLC, STATE STREET CORP, and JANUS HENDERSON GROUP PLC.
This table shows 628 institutional shareholders of the security as of 30 Jun 2021.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.